Valeria Olvera-Rodríguez,Francesca Pampaloni,Andrea Sechi et al.
Valeria Olvera-Rodríguez et al.
Scalp rosacea, also known as red scalp disease (RSD), is an inflammatory dermatosis that remains underrecognized and frequently misdiagnosed because of its clinical overlap with other inflammatory scalp disorders and the relative nonspecifi...
Effectiveness and Safety of 40 mg Modified-Release Doxycycline for the Treatment of Hidradenitis Suppurativa: A Single-Center Retrospective Observational Study [0.03%]
改良释放多西环素40毫克治疗汗腺炎的有效性和安全性：单中心回顾性观察研究
Gemma Camiña-Conforto,Luis Puig,Eva Vilarrasa
Gemma Camiña-Conforto
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory follicular disorder commonly managed with antibiotics, despite increasing antimicrobial resistance (AMR). ...
Cumulative Duration of Severe Psoriasis: A Novel Cardiovascular Risk Predictor for Dermatologists [0.03%]
严重银屑病持续时间与心血管风险评估
Bernadett B Huszti,Noémi Á Galajda,Seo-Ho Cho et al.
Bernadett B Huszti et al.
Introduction: The association between moderate-to-severe psoriasis and cardiovascular (CV) risk is well known. No clear link between disease activity, disease duration, and CV risk has been established thus far to identif...
Real-World Evidence for the Impact of Minimal Disease Activity on Quality of Life in Atopic Dermatitis: An Interim Analysis of the Prospective, Multicenter, Non-Interventional UP-TAINED Study [0.03%]
真实世界证据证明了极少数疾病活性对特应性皮炎生命质量的影响：前瞻性多中心非干预性UP-TAINED研究的中期分析
Felix Lauffer,Boris Bauer,Katharina Kreutzer et al.
Felix Lauffer et al.
Introduction: Minimal disease activity (MDA) has recently been introduced as comprehensive treatment target in atopic dermatitis (AD), integrating both clinician- and patient-reported outcomes. Evidence on the real-world ...
Treatment Patterns, Drug Survival, and Effectiveness of Tildrakizumab Among Patients with Prior Interleukin-17 Experience in the PPD CorEvitas Psoriasis Registry [0.03%]
PPD CorEvitas银屑病登记中心生物类似药使用患者群体中 tilrakizumab的治疗模式、药物生存期和疗效：既往有 IL-17抑制剂治疗经验的患者亚组分析
Mark G Lebwohl,Ranga Gogineni,Asif Shaikh et al.
Mark G Lebwohl et al.
Introduction: Tildrakizumab is an interleukin (IL)-23 p19 inhibitor approved for the treatment of adults with moderate-to-severe plaque psoriasis. This study assessed tildrakizumab effectiveness and drug survival in real-...
Real-world Tildrakizumab Effectiveness and Drug Survival: A Cohort Study in the PPD CorEvitas Psoriasis Registry [0.03%]
基于PPD CorEvitas银屑病登记处的实`tildrakizumab疗效和用药持续时间：队列研究
Jerry Bagel,Ranga Gogineni,Asif Shaikh et al.
Jerry Bagel et al.
Introduction: Tildrakizumab is an interleukin-23 p19 inhibitor approved for the treatment of adults with moderate-to-severe plaque psoriasis. While clinical trials have demonstrated tildrakizumab efficacy, studies reporti...
AD-REAL: A Prospective, Multinational, Observational Cohort Study of Clinical Effectiveness and Treatment Discontinuation of Oral Systemics for Moderate-to-Severe Atopic Dermatitis [0.03%]
AD-REAL研究：中重度特应性皮炎口服系统药物的临床疗效及停药的前瞻性、多国队列观察研究
Matthias Augustin,Andreas Pinter,Silvia Sabatino et al.
Matthias Augustin et al.
Introduction: Clinical data surrounding treatment patterns and reasons for discontinuation of oral systemics (OS) for the treatment of adult patients with moderate-severe atopic dermatitis (AD) remain limited. AD-REAL des...
Achieving Minimal Disease Activity in Atopic Dermatitis Is Associated with Fewer Flares, Reduced Healthcare Resource Utilization, and Improved Disease Control: Analysis from the Real-World MEASURE-AD Study [0.03%]
极小疾病活动度与特应性皮炎减少复发、降低医疗资源利用和改善疾病控制相关：来自真实世界MEASURE-AD研究的分析
Jonathan I Silverberg,Vimal H Prajapati,Susanne Abraham et al.
Jonathan I Silverberg et al.
Introduction: Atopic dermatitis (AD), a chronic inflammatory condition, is the leading cause of global burden from skin disease. Optimal targets for clinician-reported outcomes (ClinROs) and patient-reported outcomes (PRO...
Adverse Effects of Treatments for Anogenital Warts in Non-immunocompromised Adults: A Network Meta-analysis of Randomized Controlled Trials [0.03%]
非免疫缺陷成人尖锐湿疣治疗的不良反应：随机对照试验的网络 meta 分析
Réda Saib,Elisa Joly,Sébastien Fouere et al.
Réda Saib et al.
Introduction: International guidelines for the management of anogenital warts (AGWs) propose multiple first-line options but do not prioritize treatments based on safety or tolerability. This study aimed to compare the sa...
Prospective Evaluation of Cross-linked Sodium Hyaluronate Gel for Injection in Treating Moderate-to-Severe Nasolabial Folds: A Randomized Controlled Evaluator-Blind Non-inferiority Study [0.03%]
交联透明质酸钠凝胶注射治疗中重度鼻唇沟皱纹的有效性和安全性：一种双盲随机对照非劣效性研究
Xinlyu Huang,Yankun Zhang,Jie Dong et al.
Xinlyu Huang et al.
Introduction: This study evaluates a novel lidocaine-premixed hyaluronic acid (HA) gel for nasolabial fold (NLF) correction, addressing pain management and longevity challenges in facial rejuvenation. The aim is to assess...